Europe • Euronext Oslo • OSL:GENT • NO0010748866
Taking everything into account, GENT scores 6 out of 10 in our fundamental rating. GENT was compared to 68 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is not overvalued while it is showing excellent growth. This is an interesting combination.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROIC | 8.76% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 18.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.17 | ||
| Fwd PE | 21.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 274.32 | ||
| EV/EBITDA | 25.13 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
ChartMill assigns a valuation rating of 4 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.